Pfizer Inc. buy BMO Capital Markets
Start price
02.05.24
/
50%
€25.92
Target price
02.05.25
€33.67
Performance (%)
-17.81%
End price
03.05.25
€21.30
Summary
This prediction ended on 03.05.25 with a price of €21.30. The price of Pfizer Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.81%. Dividends of €1.58 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -1.801% | -1.801% | -14.708% |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $36.00 price target on the stock, up previously from $33.00.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten